Ranbaxy ‘misses’ milestone payment - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Ranbaxy ‘misses’ milestone payment

Oct 24, 2000

Ranbaxy has reported a net profit of Rs 531 m on a turnover of Rs 4,641 m for the third quarter ended September 2000. While the turnover has improved 13% which is slightly higher than the overall industry growth, the net profit performance is not comparable. This is because last year’s second quarter results include the technology licensing income of Rs 430 m. While the details of the gross profit, interest and depreciation are not available, the net profit quarter on quarter has improved at least over 40%. The results are in line with our projections. However we have added a milestone payment of Rs 225 m (from its deal with Bayer) which the company expects to receive in the last quarter.

The stock quotes at a price of Rs 629 which implies an earnings multiple of 34 times annualised earnings.

Equitymaster requests your view! Post a comment on "Ranbaxy ‘misses’ milestone payment ". Click here!


More Views on News

Sorry! There are no related views on news for this company/sector.

Most Popular

How the 8-Year Cycle Can Help Identify Multibaggers (Fast Profits Daily)

Sep 11, 2020

This is how you can apply the greed and fear cycle in the market to pick stocks.

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

This Could Be the Best September for Auto Stocks (Profit Hunter)

Sep 11, 2020

Here's why I think this month could be a great for auto stocks.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...


Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms


Apr 1, 2015 (Close)


  • Track your investment in RANBAXY LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks